Assignee
INCELLDX INC
US·15 granted patents·9 pending applications·30 citations·filing 2009–2023
Top patents by PatentIndex Score
24 records- 0188US11180491B2Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maravirocINCELLDX INC·Filed 2020·Granted Nov 23, 2021·2 cites·3 claims
- 0287US7888032B2HPV E6, E7 mRNA assay and methods of use thereofINCELLDX INC·Filed 2009·Granted Feb 15, 2011·22 cites·20 claims
- 0386US12228580B2Methods of assigning a COVID pathological type based on a cytokine/chemokine panelINCELLDX INC·Filed 2022·Granted Feb 18, 2025·1 cites·13 claims
- 0484US2023287526A1HPV E6, E7 MRNA Assay and Methods of Use ThereofINCELLDX INC·Filed 2023·Application pending·0 cites
- 0583US11402391B2Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonistINCELLDX INC·Filed 2021·Granted Aug 2, 2022·1 cites·18 claims
- 0682US10782298B2Methods of detecting per cell PD-L1 expression and uses thereofINCELLDX INC·Filed 2018·Granted Sep 22, 2020·2 cites·20 claims
- 0779US10627389B2Methods of assessing cellular breast samples and compositions for use in practicing the sameINCELLDX INC·Filed 2016·Granted Apr 21, 2020·2 cites·10 claims
- 0875US9464332B2HPV E6, E7 MRNA assay and methods of use thereofINCELLDX INC·Filed 2014·Granted Oct 11, 2016·0 cites·10 claims
- 0971US2018230556A1HPV E6, E7 MRNA Assay and Methods of Use ThereofINCELLDX INC·Filed 2018·Application pending·0 cites
- 1070US12298309B2Methods of assaying neoplastic and neoplasia-related cells and uses thereofINCELLDX INC·Filed 2023·Granted May 13, 2025·0 cites·12 claims
- 1170US11952373B2Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maravirocINCELLDX INC·Filed 2021·Granted Apr 9, 2024·0 cites·14 claims
- 1267US2017067127A1HPV E6, E7 MRNA Assay and Methods of Use ThereofINCELLDX INC·Filed 2016·Application pending·0 cites
- 1366US11629196B2Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactionsINCELLDX INC·Filed 2020·Granted Apr 18, 2023·0 cites·12 claims
- 1464US12516390B2Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cellsINCELLDX INC·Filed 2017·Granted Jan 6, 2026·0 cites·7 claims
- 1564US2025205209A1Methods of Treating a Subject for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Compositions for Use in The SameINCELLDX INC·Filed 2023·Application pending·0 cites
- 1662US11988658B2Methods of assessing cellular breast samples and compositions for use in practicing the sameINCELLDX INC·Filed 2020·Granted May 21, 2024·0 cites·11 claims
- 1760US10167526B2Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cellsINCELLDX INC·Filed 2015·Granted Jan 1, 2019·0 cites·22 claims
- 1859US2024019447A1Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19INCELLDX INC·Filed 2023·Application pending·0 cites
- 1958US2025099444A1Methods of Treating a Subject for Long-Haul COVID-19, and Compositions for Use in the SameINCELLDX INC·Filed 2023·Application pending·0 cites
- 2057US11726089B2Methods of assaying neoplastic and neoplasia-related cells and uses thereofINCELLDX INC·Filed 2019·Granted Aug 15, 2023·0 cites·7 claims
- 2148US2014199722A1Methods for determining whether a cervical cellular sample should be tested for cervical cancer, and devices and kits for practicing the sameINCELLDX INC·Filed 2014·Application pending·0 cites
- 2245US10308990B2Methods of evaluating a cellular sample for latent cellular replication competent HIV-1INCELLDX INC·Filed 2015·Granted Jun 4, 2019·0 cites·21 claims
- 2344US2022107320A1Assaying Bladder-Associated Samples, Identifying and Treating Bladder-Associated Neoplasia, and Kits for Use ThereinINCELLDX INC·Filed 2020·Application pending·0 cites
- 2444US2021341484A1Methods for Detecting Cancer-Related Cell Populations, Screening for Metastatic Cancer and Treatments ThereofINCELLDX INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →